Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07362862 · ClinicalTrials.gov registry record · NA
MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Mitigate ICU Acquired Weakness in Medical ICU Patients
A NA study, sponsored by Health Discovery Labs.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07362862 is a NA study that is actively recruiting participants, run by Health Discovery Labs. The registered enrollment target is 50 participants.
The verdict
NCT07362862, a NA study, is actively recruiting participants, sponsored by Health Discovery Labs.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if a new medical device that sends electrical signals to the thigh muscles is safe and easy to use for people in the ICU (Intensive Care Unit) who are at risk of losing muscle strength. It will also explore whether this treatment can help slow down muscle weakening. The main questions this study aims to answer are: * Do participants develop medical problems when receiving electrical muscle stimulation in the ICU? * Is electrical muscle stimulation a practical way to help reduce muscle weakness in critically ill patients? Researchers will compare the control group (standard of care) to the intervention group (standard of care plus 60-minute sessions of electrical muscle stimulation daily during the ICU stay) to see if the device is safe and easy to use. Participants will: * Receive either standard of care or standard of care plus electrical muscle stimulation of the thigh muscles * Have their muscle strength checked during the study * Complete a survey three months after ICU discharge to check on their recovery
Interventions
- DEVICE Electrical Muscle Stimulation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-05-05 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07362862
The ClinicalTrials.gov registry entry for NCT07362862 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Health Discovery Labs, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electrical Muscle Stimulation System is the first listed.
NCT07362862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07362862 about?
NCT07362862 is a clinical study titled "MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Mitigate ICU Acquired Weakness in Medical ICU Patients". The goal of this clinical trial is to learn if a new medical device that sends electrical signals to the thigh muscles is safe and easy to use for people in the ICU (Intensive Care Unit) who are at risk of losing muscle strength. It will also explore whether this treatment can help slow down muscle ...
What is the current status of trial NCT07362862?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-05-05. Estimated completion is 2027-08-31.
What interventions are being tested in trial NCT07362862?
The interventions under investigation include: Electrical Muscle Stimulation System (DEVICE).
Who is sponsoring clinical trial NCT07362862?
This trial is sponsored by Health Discovery Labs, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.